Easton Pharmaceuticals announced the appointment of Dr. Daniel Bagi, MD as Director, President of Business Development. Dr. Daniel Bagi is a senior executive physician with 27 years international experience in the pharmaceutical industry, with an emphasis in worldwide business development and licensing. Dr. Bagi has expertise in medical affairs and clinical research, specifically oncology and specialty women’s health products and an excellent knowledge of international regulatory standards. Dr. Bagi has supervised over 15 international clinical trials. More recently Dr. Bagi was instrumental in securing sub-licensing agreements for Easton and its Latin American joint venture partner, BMV Medica SA de CV with BAYER for the Bacterial Vaginosis diagnostic product VS-Sense for Mexico, which is already available in Canada, Europe and the USA under different brand names. Product launch is expected to commence in the 4th quarter of 2018. Mr. Bagi takes over for Carla Pepe who has left the company for other opportunities in Canada. Mr. Bagi joins Mr. Luigi Gentile, John Guerra, Evan Karras and Robert Vivacque as board members of Easton Pharmaceuticals with announcements and restructuring of corporate positions to soon be announced.